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Summary
TNF is a pleiotropic cytokine that induces either cell
proliferation or cell death. Inhibition of NF-B activa-
tion increases susceptibility to TNF-induced death,
concurrent with sustained JNK activation, an impor-
tant contributor to the death response. Sustained JNK
activation in NF-B-deficient cells was suggested to
depend on reactive oxygen species (ROS), but how
ROS affect JNK activation was unclear. We now show
that TNF-induced ROS, whose accumulation is sup-
pressed by mitochondrial superoxide dismutase,
cause oxidation and inhibition of JNK-inactivating
phosphatases by converting their catalytic cysteine
to sulfenic acid. This results in sustained JNK activa-
tion, which is required for cytochrome c release and
caspase 3 cleavage, as well as necrotic cell death.
Treatment of cells or experimental animals with an an-
tioxidant prevents H2O2 accumulation, JNK phospha-
tase oxidation, sustained JNK activity, and both forms
of cell death. Antioxidant treatment also prevents
TNF-mediated fulminant liver failure without affect-
ing liver regeneration.
Introduction
Tumor necrosis factor (TNF)α is a pleiotropic cytokine
that triggers either cell proliferation, cell death, or in-
flammation through two distinct receptors: TNF recep-
tor (TNFR) 1 and 2 (Wajant et al., 2003). These re-
sponses depend on effector pathways, including
mitogen-activated protein kinases (MAPKs) that acti-
vate AP-1 transcription factors and IκB kinases (IKK)
that activate NF-κB (Brenner et al., 1989; DiDonato et
al., 1997; Liu et al., 1996).
NF-κB is a major negative regulator of programmed
cell death (PCD), especially in response to TNFα and
similar cytokines (Karin and Lin, 2002). If NF-κB activa-
tion is prevented, TNFα can induce either apoptotic or
necrotic cell death (Fiers et al., 1999). Several mecha-
nisms account for this activity of NF-κB, including in-*Correspondence: karinoffice@ucsd.eduduction of antiapoptotic members of the Bcl2 family and
caspase inhibitors (Karin and Lin, 2002). Another less
understood mechanism entails inhibition of sustained
Jun N-terminal kinase (JNK) activation (De Smaele et
al., 2001; Sakon et al., 2003; Tang et al., 2001). Initially,
JNK activation was found not to be required for PCD in
certain types of cells treated with TNFα plus inhibitors
of RNA or protein synthesis (Liu et al., 1996). However,
the use of such inhibitors can result in artifactual results
(Deng et al., 2003), and it is generally agreed that in
cells lacking the major activating subunit of NF-κB, Re-
lA(p65), the IKKβ subunit of the IKK complex or up-
stream components of the TNFR1 signaling machinery,
JNK activation is an important mediator of PCD. Cer-
tain cytokines, drugs, or viruses may also interfere with
NF-κB activation and thereby cause sustained JNK ac-
tivation and enhance TNFα-induced PCD in genetically
normal subjects.
In NF-κB-competent cells, TNFα leads to rapid but
transient JNK activation that after peaking within 15–30
min is terminated within 60 min (Liu et al., 1996), due to
the action of JNK phosphatases (Cavigelli et al., 1996).
This response is dramatically extended in NF-κB-defi-
cient cells (De Smaele et al., 2001; Tang et al., 2001) or
mice (Maeda et al., 2003). Whereas administration of
lipopolysaccharide (LPS) to mice lacking IKKβ in liver
cells (IkkbDhep mice) results in transient JNK activation
and little liver injury, administration of concanavalin A
(ConA), a pan-T cell activator, causes sustained JNK
activation, massive liver cell death (both apoptosis and
necrosis), and liver failure (Maeda et al., 2003). Similar
hepatotoxicity is observed in wild-type (wt) mice ex-
posed to higher concentrations of ConA or a combin-
ation of ConA and N-acetyl-galactosamine, a toxic
compound that blocks transcription in hepatocytes.
ConA-induced hepatitis is a reasonable model for ful-
minant liver failure in humans, and it is likely that other
hepatotoxins or viruses that cause acute liver failure
may do so through inhibition of NF-κB. JNK-deficient
mice are relatively immune to these toxic challenges,
exhibiting considerably less liver apoptosis and necro-
sis (Maeda et al., 2003). Unlike ConA challenge, partial
hepatectomy, which also induces TNFα expression,
causes transient JNK activation that like its upstream
activator, TNFR1 (Yamada et al., 1997), is instrumental
in liver regeneration (Schwabe et al., 2003). For thera-
peutic purposes, it is desirable to convert the TNFα-
mediated death response to a regenerative response.
We thus wished to further understand how reduced NF-
κB activity leads to sustained JNK activation and con-
sequently more PCD in ConA-challenged mice.
Several mechanisms were proposed to explain the
crosstalk between NF-κB and JNK, including induction
of GADD45β (De Smaele et al., 2001) and XIAP (Tang et
al., 2001). However, analysis of Gadd45b−/− or Xiap−/−
fibroblasts failed to reveal changes in the kinetics of
JNK activation (Amanullah et al., 2003; Kucharczak et
al., 2003). More recently, it was suggested that reactive
oxygen species (ROS), whose production is induced by
TNFα, are responsible for sustained JNK activation (Sa-
Cell
650kon et al., 2003). Whereas XIAP and GADD45β inhibit a
iPCD (Deveraux et al., 1997; Smith et al., 1996), ROS
production causes cell death (Fiers et al., 1999). Curi- t
sously, NF-κB activates the SOD2 gene, which encodes
a mitochondrial form of the antioxidant enzyme super- l
doxide dismutase (SOD) that inhibits TNFα-induced PCD
(Wong et al., 1989). TNFα-induced PCD can also be c
esuppressed by chemical antioxidants, such as butyl-
ated hydroxyanisole (BHA) (Goossens et al., 1995; Sa- T
fkon et al., 2003; Vercammen et al., 1998). Although such
results underscore a role for ROS in PCD, a defined target d
cfor ROS-mediated oxidation that promotes TNFα-induced
death was lacking (Cai and Jones, 1998; Fiers et al.,
p1999).
We undertook a detailed investigation of the pro- t
3posed involvement of ROS in the crosstalk between
NF-κB and JNK and TNFα-induced PCD. We confirmed C
sthat exposure of NF-κB-deficient cells to TNFα, but not
IL-1, results in massive but delayed H2O2 accumulation. a
3Increased oxidative stress is also seen in ConA-chal-
lenged IkkbDhep mice. Importantly, intracellular H2O2 ac- 1
cumulation inactivates MAPK phosphatases (MKPs), by
oxidation of their catalytic cysteine. This leads to sus- M
tained activation of JNK and p38 MAPK. Expression of a
catalytically inactive MKPs prolongs JNK activation M
and potentiates TNFα-induced killing of NF-κB-compe- t
tent cells. TNFα-induced PCD is also potentiated by e
inhibition of thioredoxin (Trx)-reductase (TrxR), an en- M
zyme whose activity is required for recycling of oxi- e
dized MKPs. Inhibition of ROS accumulation preserves R
MKP activity, blocks sustained JNK activation, and pre- b
vents ConA-induced liver destruction, but has no effect l
on liver regeneration after partial hepatectomy. M
4
(Results
c
PTNF-Induced ROS Cause Sustained JNK Activation
sand Cell Death
RWe examined JNK and p38 activation in mouse fibro-
blasts that are either wt or deficient for either IKKβ or
RelA(p65). As expected, JNK and p38 were transiently I
iactivated by either TNFα or IL-1 in wt fibroblasts. TNFα,
but not IL-1, led to sustained JNK and p38 activation in A
pboth RelA- and IKKβ-deficient fibroblasts (Figure S1A).
As shown previously (Sakon et al., 2003), BHA sup- n
tpressed the sustained phase of JNK and p38 activation
in RelA- and IKKβ-deficient fibroblasts, restoring tran- J
ksient kinase activation (Figure S1A). As TNFα is a poor
activator of ERK in fibroblasts, we were not able to ex- (
(amine whether BHA or NF-κB deficiency affect ERK ac-
tivity. b
tSensitivity to BHA suggested the involvement of ROS
in sustained MAPK activation. Indeed, flow cytometric i
eanalysis of cells incubated with the H2O2-sensitive fluo-
rescent dye, CM-H2DCFDA, confirmed substantial ac- a
pcumulation of H2O2 in RelA- and IKKβ-deficient fibro-
blasts after TNFα treatment but not after incubation t
mwith IL-1 (Figure S1B and data not shown). The kinetics
of ROS accumulation were slow and paralleled those t
vof TNFα-induced PCD (Figure 1A). BHA suppressed
TNFα-induced ROS accumulation (Figures 1A and S1B) t
fand conferred resistance to PCD (Figure 1A). TNFα can
induce either apoptotic or necrotic cell death (Fiers et el., 1999), and BHA was shown to mainly suppress TNFα-
nduced necrosis (Sakon et al., 2003). To examine the
ype of PCD induced by TNFα in Ikkb−/− cells, we mea-
ured permeability to propidium iodide (PI) to monitor
oss of membrane integrity—a general marker of cell
eath and changes in cell volume. Apoptosis reduces
ell volume, whereas necrosis does not (Vanden Berghe
t al., 2004). Flow cytometric analysis revealed that
NFα induced both apoptosis and necrosis of Ikkb−/−
ibroblasts and that BHA suppressed both types of
eath (Figure 1B). Both forms of death were induced
oncomitantly (Figures S2 and S3).
Consistent with a role for ROS in TNFα-induced apo-
tosis, the kinetics of H2O2 production were similar to
hose of cytochrome c release and cleavage of caspase
, both of which were prevented by BHA (Figure 1C).
ytochrome c release and caspase 3 cleavage are also
een upon ConA administration to mice. Both TNFα-
nd ConA-induced cytochrome c release and caspase
cleavage were blocked by deletion of JNK1 (Figure
D and data not shown).
nSOD Suppresses TNF-Induced ROS Production
nd Cell Death
nSOD is an important NF-κB-dependent antioxidant
hat can protect cells from TNFα-induced PCD (Wong
t al., 1989). We confirmed that TNFα markedly induced
nSOD in wt but not Ikkb−/− fibroblasts (Figure 1E). To
xamine whether MnSOD deficiency contributes to
OS accumulation, we stably transfected Ikkb−/− fibro-
lasts with an MnSOD expression vector and estab-
ished pooled Ikkb−/− (MnSOD) cells, in which ectopic
nSOD was constitutively expressed, but only at 30%–
0% of the amount seen in TNFα-treated wt fibroblasts
Figure 1E). Nonetheless, this was sufficient to signifi-
antly inhibit TNFα-induced H2O2 accumulation and
CD (Figures 1F and 1G). Thus, the mitochondrion, the
ite of MnSOD expression, is an important source of
OS in TNFα-stimulated Ikkb−/− cells.
nhibition of JNK Phosphatases
n TNF-Treated Cells
ll MAPKs are activated through tyrosine and threonine
hosphorylation at their activation loops by MAPK ki-
ases (MKKs) and are inactivated by dephosphoryla-
ion of the same sites by MKPs (Davis, 2000). Sustained
NK activation could therefore involve either an upstream
inase or inhibition of JNK phosphatases. A MKK kinase
MAP3K) responsive to both TNFα and H2O2 is ASK1
Takeda et al., 2003). However, no ASK1 activation could
e detected using a phospho-ASK1 antibody in TNFα-
reated wt or NF-κB-deficient fibroblasts or in ConA-
njected mice (H.K., unpublished data). We therefore
xamined the involvement of JNK phosphatases, which
s members of the MKP subgroup of protein tyrosine
hosphatases (PTPs) share the PTP signature motif at
heir catalytic pocket (Figure 2A). A key feature of this
otif is the catalytic cysteine which is highly sensitive
o oxidation due to its low pKa (Salmeen et al., 2003;
an Montfort et al., 2003). Indeed, several PTPs are
ransiently inactivated in cells treated with growth
actors through oxidation of their catalytic cysteine (Lee
t al., 1998; Meng et al., 2002). Inactivation of PTPs
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651Figure 1. ROS and JNK Are Required for TNFα-Induced Cytochrome c Release, Caspase 3 Cleavage, and PCD
(A) Timecourse of TNFα-induced cell death and H2O2 production in Ikkb−/− fibroblasts. Cells were incubated with TNFα in the presence or
absence of BHA (100 M). Cell viability was assessed by Trypan-blue dye exclusion. H2O2 production was measured by flow cytometry of
cells loaded with 1 M CM-H2DCFDA for 30 min prior to each time point. Bar graph: fluorescent intensity of cells loaded with CM-H2DCFDA
and incubated with H2O2 for 30 min.
(B) TNFα induces apoptosis and necrosis. Ikkb−/− fibroblasts were left untreated or treated with TNFα without or with BHA. After 12 hr, cell
viability and volume were measured by flow cytometry. Upper panels: membrane integrity assessed by dye exclusion using PI. Lower panels:
the volume of PI-positive (red dots) and PI-negative (green dots) cells was monitored by side scatter (SSC) versus forward scatter (FSC).
Apoptosis (A) is associated with decreased FSC of PI-positive cells. Necrosis (N) correlates with little or no change in FSC of PI-positive cells.
Side panel: the percentage of apoptosis (A) and necrosis (N) in the different treatment groups.
(C) BHA suppresses TNFα-induced cytochrome c release and caspase 3 cleavage. Ikkb−/− fibroblasts were incubated with TNFα in the
absence or presence of BHA for the indicated periods and cytochrome c release and caspase 3 cleavage (act.) were monitored.
(D) JNK1 is required for cytochrome c release and caspase 3 cleavage in vivo. wt and Jnk1−/− mice were injected with 25 mg/kg of ConA. At
the indicated times, mice were sacrificed and their livers removed and homogenized. Postmitochondrial supernatants were analyzed for
cytochrome c content, caspase 3 cleavage, JNK1, and actin levels.
(E) TNFα induces MnSOD expression in an IKKβ-dependent manner. wt, Ikkb−/−, and Ikkb−/− (MnSOD) fibroblasts were incubated with or
without TNFα for 8 hr and MnSOD levels were analyzed by immunoblotting.
(F) MnSOD suppresses ROS accumulation. Fibroblasts were incubated without or with TNFα for 8 hr and DCF fluorescence analyzed as in (A).
(G) Timecourse of TNFα-induced cell death in wt, Ikkb−/−, and Ikkb−/− (MnSOD) fibroblasts.
Cell
652Figure 2. TNFα Inhibits JNK Phosphatase
Activity in NF-κB-Deficient Fibroblasts
(A) Schematic representation of MKP-3
structural organization and the conserved
catalytic motif.
(B) TNFα down-modulates JNK-phospha-
tase activity. Cells were incubated without or
with TNFα in the absence or presence of
BHA for 8 hr, and lysed. Lysates were incu-
bated with phosphorylated JNK1 at 37°C for
the indicated periods and JNK1 dephosphor-
ylation was monitored by immunoblotting
with anti-phospho-JNK antibody.is thought to facilitate and prolong activation of their m
ttarget kinases.
To investigate whether JNK phosphatases are inacti- a
mvated during TNFα treatment, we incubated activated
JNK1 with lysates of untreated and TNFα-treated cells M
win a phosphatase buffer and monitored dephosphoryla-
tion of its activation loop with an anti-phospho-JNK an- F
ttibody. Rapid and invariant JNK1 dephosphorylation
was seen upon incubation with lysates of nonstim- A
dulated wt or NF-κB-deficient cells (Figure 2B). Treat-
ment of wt fibroblasts with TNFα had no effect on JNK M
dphosphatase activity, but diminished JNK dephosphor-
ylation was found upon incubation with lysates of b
oTNFα-treated NF-κB-deficient cells (Figure 2B). Coin-
cubation of these cells with BHA prevented the TNFα- o
uinduced decrease in JNK phosphatase activity. Hence,
sustained JNK activation is likely to entail inactivation m
pof JNK phosphatases.
dTNF-Induced MKP Oxidation
To examine TNFα-induced MKP inhibition in more de- b
ftail, we focused on MKP-1, MKP-3, MKP-5, and MKP-7,
all of which function as JNK phosphatases (Masuda et M
Ial., 2001; Sanchez-Perez et al., 2000; Tanoue et al.,
2001). Initially, HeLa cells were treated with various m
oconcentrations of H2O2, and lysates were prepared and
separated by SDS-PAGE in the absence of β-mercapto- b
pethanol (βME) or other reducing agents. As oxidized
MKP-1 is rapidly degraded by the proteasome (data not s
cshown), we incubated cells with a proteasome inhibitor,
MG132, to inhibit its degradation. Immunoblotting re- a
Mvealed a marked dose-dependent shift in the electro-
phoretic mobility of MKP-1 in H O -treated cells to high c2 2olecular weight (HMW) species that barely entered
he gel (Figure 3A). Incubation of the lysates with βME
bolished this mobility shift, suggesting that the slow
igrating MKP-1 forms are mixed disulfides between
KP-1 and HMW proteins (Figure 3A). Next, HeLa cells
ere transfected with expression plasmids encoding
lag-tagged wt MKPs or mutant counterparts in which
he catalytic cysteine was replaced with a serine.
gain, immunoblot analysis revealed a marked dose-
ependent shift in the electrophoretic mobility of all
KPs in H2O2-treated cells (Figures 3B and 3C and
ata not shown). Formation of these HMW forms, which
arely entered the gel, was suppressed by conversion
f the catalytic cysteine to a serine. Note that instead
f full-length MKP-7, which is poorly expressed, we
sed a deletion mutant which retained the catalytic do-
ain. Even this truncated protein formed HMW com-
lexes upon oxidation.
Next, we examined the effect of endogenously pro-
uced ROS generated by incubation of Ikkb−/− fibro-
lasts with TNFα. wt and Ikkb−/− fibroblasts were trans-
ected with either wt or mutant Flag-tagged MKP-1 and
KP-3 and Myc-tagged MKP-5 expression vectors.
mmunoblot analysis demonstrated that TNFα treat-
ent of transfected Ikkb−/− cells induced HMW forms
f wt MKP-1, MKP-3, and MKP-5 that were abolished
y incubation with βME (Figures 3D, 3F, and 3G). Ap-
earance of the oxidized MKP forms, which was not
een in wt cells, was prevented by incubating Ikkb−/−
ells with BHA, suggesting that endogenously gener-
ted ROS cause MKP oxidation. As seen with H2O2,
KP oxidation was prevented by replacement of the
atalytic cysteine with serine (Figures 3D and 3F). Ti-
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653Figure 3. MKPs Are Oxidized in TNFα-Treated IKKβ-Deficient Cells
(A) HeLa cells were treated with the indicated concentrations of H2O2 for 10 min in the presence of MG132 (50 M).
(B–G) Flag-tagged MKP-1 (B, D, and E), Myc-tagged MKP-7C (C), Flag-tagged MKP-3 (F), Myc-tagged MKP-5 (G), and their catalytic cysteine
mutants were transiently expressed in HeLa cells, wt, or Ikkb−/− fibroblasts, as indicated. HeLa cells were treated with H2O2 for 10 min (B and
C). wt and Ikkb−/− fibroblasts were treated with TNFα in the absence or presence of BHA for 12 hr (D, F, and G) or the indicated times (E).
Cells expressing MKP-1 were also incubated with MG132 to block degradation of oxidized MKP-1. All cells were lysed in a buffer containing
10 mM NEM to prevent oxidation of cysteines during sample preparation. Lysates were fractionated by SDS-PAGE in the absence or presence
of 250 mM βME as indicated and analyzed by immunoblotting. MKP oxidation was monitored by changes in electrophoretic mobility. Ox—
oxidized MKP, Red—reduced MKP, ns—nonspecific band.mecourse analysis revealed that the shift in MKP-1
electrophoretic mobility was barely detectable at 4 hr
of incubation of Ikkb−/− cells with TNFα but was nearly
maximal at 8 hr (Figure 3E).
Consistent with these biochemical data, immunoflu-
orescent staining of transfected Cos7 cells revealed
aggregation of Flag-MKP-3 after H2O2 treatment (Figure
4A). Such aggregates were not formed by Flag-MKP-
3(C293S). Similar results were obtained when wt and
mutant Flag-MKP-3 were expressed in Ikkb−/− fibro-
blasts. In this case, treatment with TNFα induced the
aggregation of wt Flag-MKP-3 but did not alter the dis-
tribution of a Flag-MKP-3 (C293S) mutant (Figure 4B).
To confirm the critical role of the catalytic cysteine in
MKP oxidation, we generated and analyzed nine dif-
ferent mutants of MKP-3, replacing each cysteine with
a serine. Only the catalytic cysteine mutant, C293S, did
not exhibit any phosphatase activity and was resistant
to H2O2-induced oxidation (Figure S4). Similar results
were obtained either in vitro or in intact cells, indicating
that the catalytic cysteine is responsible for MKP oxi-
dation.
MKP Oxidation Results
in Formation of Sulfenic Acid
Cysteine oxidation by H2O2 results in formation of either
sulfenic (-SOH), sulfinic (-SO2H), or sulfonic (-SO3H) acid,
representing addition of one, two, or three oxygens,
respectively. Whereas sulfenic acid is relatively unsta-
ble and readily reacts with other thiols to generate adisulfide, which can be reverted to the original cysteine
upon reduction, the sulfonic and sulfinic acid forms
represent irreversible end products (Claiborne et al.,
1999). To determine which form of oxidation was in-
flicted upon the catalytic cysteine of MKP-3 we incu-
bated purified GST-MKP-3 with H2O2. This resulted in
dose-dependent inhibition of phosphatase activity with
an IC50 around 0.3 mM H2O2 (Figure 5A). Fully oxidized
MKP-3 was partially reactivated by addition of DTT, in-
dicating that reversible and irreversible modifications
were involved (Figure 5A). To measure the redox state
of its catalytic cysteine, GST-MKP-3 was incubated
with the thiol reactive fluorescent dye fluorescein-
5-maleimide (F5M). Unoxidized MKP-3 was efficiently
labeled by F5M, whereas MKP-3 pretreated with 3 mM
H2O2 was hardly labeled at all (Figure 5A). Addition of
DTT to oxidized MKP-3 partially recovered its F5M reac-
tivity and phosphatase activity. The H2O2-induced elec-
trophoretic mobility shifts were also dose dependent
and paralleled inhibition of phosphatase activity and
F5M reactivity (Figure 5B). Nonetheless, no obvious
mobility shift was detected upon incubation of MKP-3
with 0.3 mM H2O2, a dose that caused more than 50%
inhibition. Although prolonged incubation of purified
GST-MPK-3 with H2O2 led to formation of large oligo-
mers (Figure 5B), short incubation generated smaller
oligomers (Figure S4D).
We used mass spectrometry (MS) to determine the
exact oxidation state of C293 or MKP-3. To prevent po-
tential signals caused by oxidation of C287 and M309,
Cell
654FFigure 4. Oxidation-Induced MKP Aggregation in Cells Depends on
Mthe Catalytic Cysteine
((A) Cos7 cells and (B) Ikkb−/− fibroblasts were transfected with Flag-
Ptagged wt MKP-3 or its catalytic cysteine mutant (C293S). (A) Cos7
tcells were left untreated or treated with 3 mM H2O2 for 10 min. (B)
aIkkb−/− fibroblasts were left untreated or treated with TNFα for 12
rhr. The cells were fixed, stained with anti-Flag antibody, and ana-
alyzed by indirect immunofluorescence.
t
aigure 5. Sulfenic Acid Formation Is Responsible for ROS-Mediated
KP Inactivation
A) H2O2 induces reversible and irreversible MKP-3 inactivation.
urified GST-MKP-3 was treated with 5 mM DTT to reduce its cys-
eines and then transferred into a DTT-free buffer containing H2O2,
s indicated. After 10 min, GST-MKP-3 was isolated and transfer-
ed into a buffer containing the indicated concentrations of DTT
nd its activity measured by PNPP hydrolysis (upper panel). After
he phosphatase assay, GST-MKP-3 was labeled with the thiol re-
ctive dye F5M, digested with thrombin, and subjected to SDS-
PAGE to separate the GST and MKP-3 moieties. The extent of F5M
labeling was examined by fluorography (bottom panel).
(B) H2O2 induces formation of large GST-MKP-3 complexes. GST-
MKP-3 and GST-MKP-3(C293S) were incubated with the indicated
concentrations of H2O2 for 10 min. The proteins were separated by
SDS-PAGE in the absence or presence of 250 mM βME and stained
with Coomassie Brilliant Blue (CBB).
(C) H2O2 induces sulfenic acid formation. Purified MKP-3(C287S/
M309S) was treated with the indicated concentrations of H2O2 fol-
lowed by digestation with lysil-endopeptidase. The digests were
subjected to MS in the absence or presence of 100 mM DTT. The
shift in molecular mass (Mr) of the active site-containing peptide
was analyzed.which are located within the same proteolytic fragment
as C293, we converted these residues to serines. The
redox sensitivity of MKP-3 and its activity were not
changed by these mutations (data not shown). Purified
MKP-3(C287S/M309S) was treated with H2O2 and di-
gested with lysil-endopeptidase. The mass of the pep-
tide containing C293 was monitored by MS. Incubation
with H2O2 decreased the signal corresponding to re-
duced C293 and shifted the relative molecular mass by
+16, +32, or +48 dalton (corresponding to sulfenic, sul-
finic, or sulfonic acid derivatives, respectively) (Figure
5C). The +32 and +48 shifts were not fully abolished
by DTT addition but the signal corresponding to fully
reduced C293 had reappeared (Figure 5C). This is con-
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corresponding to the sulfenic acid was not detected in
fully oxidized MKP-3 before or after DTT treatment, the
reduced cysteine must have originated from a disulfide.
Thus, H2O2 can cause either irreversible C293 oxidation
to sulfinic or sulfonic acid or reversible oxidation to a
sulfenic acid or a disulfide. Although conversion of
C293 to sulfenic acid inhibits MKP-3 activity, it does
not retard its electrophoretic mobility. The latter re-
quires formation of disulfides.
Inhibition of MKP Activity Allows TNF
to Kill wt Cells
Cellular reductases are essential for maintaining the ac-
tivity of many enzymes, especially those that rely on a
reduced cysteine (Georgiou and Masip, 2003). We ex-
amined whether oxidized MKP-3 can be reduced in
cells. HeLa cells expressing Flag-MKP-3 were incu-
bated with 3 mM H2O2 for 15 min and then switched to
normal medium. Within 10 min of H2O2 removal, re-
duced MKP-3 had reappeared (Figure 6A). Cellular re-
ductases depend on either reduced glutathione (GSH)
or Trx as reducing equivalents (Georgiou and Masip,
2003; Holmgren, 2000). To evaluate the relative impor-
tance of the two for reduction of oxidized MKP-3, we
incubated transfected HeLa cells with either buthio-
ninesulfoximine (BSO), an inhibitor of GSH synthesis,
or 2,4-dinitro-1-chlorobenzene (DNCB), which prevents
recycling of Trx by inhibiting TrxR. Whereas BSO had
little effect (although it decreased the level of GSH at
least 90%), DNCB completely prevented reduction of
MKP-3 (Figure 6A). Similar results were obtained with
Flag-MKP-1, Myc-MKP-5, and Myc-MKP-7 (data not
shown). Therefore, reduction of oxidized MKPs requires
Trx-dependent reductases, such as peroxiredoxins
(Georgiou and Masip, 2003).
Incubation of wt fibroblasts with DNCB or H2O2 pro-
longed JNK activation and potentiated the response to
TNFα (Figure 6B), which in untreated cells is transient
(Figure S1A). Importantly, treatment of wt fibroblasts
with DNCB, H2O2, or As3+, a potent inhibitor of JNK
phosphatases (Cavigelli et al., 1996), allowed their kill-
ing by TNFα (Figure 6C). This enhancement of TNFα-
induced PCD was not seen in Jnk1−/− fibroblasts (Fig-
ure 6C). Thus, the effect of the different inhibitors on
cell killing is relatively specific and depends on JNK ac-
tivation.
To genetically test the involvement of MKP inactiva-
tion in TNFα-mediated PCD, we transfected wt fibro-
blasts with expression vectors encoding either wt or
catalytically inactive MKPs, which act in a dominant-
negative fashion (Masuda et al., 2001; Sanchez-Perez
et al., 2000). Whereas wt MKPs suppressed TNFα-
mediated transient JNK activation, the MKP mutants
enhanced and prolonged JNK activity (Figure 6D). Next,
we transfected wt fibroblasts with a GFP expression
vector along with either wt or catalytically inactive MKP
expression vectors and monitored the viability of trans-
fected cells. TNFα did not diminish viability of cells
transfected with either GFP plasmid alone or together
with wt MKP expression vectors, but in cells cotrans-
fected with mutant MKP expression vectors TNFα
markedly decreased cell viability (Figure 6E). These re-sults strongly suggest that MKP inactivation plays an
important role in JNK-dependent TNFα-induced PCD.
The Antioxidant BHA Prevents ConA-Induced
Liver Injury
Intravenous administration of ConA to mice causes se-
vere liver injury that depends on TNFα and JNK signal-
ing and is potentiated by inhibition of NF-κB (Maeda et
al., 2003). To examine whether TNFα-induced ROS are
involved in sustained JNK activation during ConA-
induced liver failure, we examined the levels of reduced
GSH in livers of untreated and treated mice because
the DCFDA fluorescence assay cannot be used in vivo.
Injection of wt mice with the subtoxic dose of 10 mg/
kg ConA modestly decreased the level of GSH, but in-
jection of wt mice with the toxic dose of 25 mg/kg ConA
or injection of IkkbDhep mice with 10 mg/kg ConA, to
which they respond with fulminant hepatitis (Maeda et
al., 2003), resulted in a marked drop in GSH (Figure 7A).
A more modest decrease in reduced GSH was seen in
Jnk1−/− mice, suggesting a possible contribution of
JNK to oxidative stress (Figure 7A). Thus, as in tissue
culture, exposure of hepatocytes to a cytotoxic form of
TNFα (which is induced by ConA) results in oxidative
stress that is exacerbated by absence of IKKβ. Expo-
sure of wt mice to 25 mg/kg of ConA also resulted in
decreased JNK phosphatase activity (Figure 7B) and
prolonged JNK activation (Figure 7C).
To prevent ROS accumulation, we fed mice with a
BHA-containing diet for 2 days before ConA admin-
istration. In mice kept on a normal diet, injection of
ConA markedly increased the circulating levels of ala-
nine aminotransferase (ALT), a marker of liver necrosis,
but this increase was strongly suppressed by BHA ad-
ministration (Figure 7D). BHA administration also re-
duced the number of apoptotic, TUNEL-positive hepa-
tocytes induced by ConA (Figure 7E) as well as the
magnitude and duration of ConA-induced JNK activa-
tion (Figure 7C). Thus, ROS are likely to be important
mediators of ConA-induced liver damage, as seen in fi-
broblasts.
Another TNFα- and JNK-dependent response is liver
regeneration (Schwabe et al., 2003; Yamada et al.,
1997). By contrast to ConA-induced liver failure, liver
regeneration after partial hepatectomy is associated
with modest and transient JNK activation (Schwabe et
al., 2003). The magnitude and kinetics of JNK activation
in response to partial hepatectomy were not affected
by BHA administration (Figure 7C), which also had no
effect on the kinetics or extent of liver regeneration
(Figures 7F and 7G).
Discussion
ROS, MKPs, and Modulation of TNF Signaling
Binding of TNFα to TNFR1 generates diverse biological
outcomes, including the diametrically opposed re-
sponses of cell proliferation and cell death (Wajant et
al., 2003). The exact outcome depends on the context
and cell type in which TNFR1 is activated. Although ac-
tivation of TNFR1 by soluble TNFα is insufficient for
triggering PCD (Grell et al., 1995; Maeda et al., 2003),
the death response is strongly augmented by inhibition
Cell
656Figure 6. Inactivation of MKPs Stimulates
TNFα-Induced PCD through JNK Activation
(A) Reduction of oxidized MKPs depends on
the Trx system. Flag-tagged MKP-3 was
transiently expressed in HeLa cells. Follow-
ing incubation with 300 M BSO for 24 hr
or 100 M DNCB for 15 min, the cells were
incubated with 3 mM H2O2 and 10 g/ml
cycloheximide for 15 min to oxidize pre-
viously synthesized Flag-MKP-3. The me-
dium was changed to H2O2-free medium
containing cycloheximide. At the indicated
times, cells were lysed in a buffer containing
10 mM NEM and MKP-3 oxidation was ana-
lyzed by SDS-PAGE as described in Figure 3.
(B) Activation of JNK by DNCB and H2O2. wt
fibroblasts were incubated for the indicated
times without or with TNFα in the absence
or presence of DNCB (10 M) or H2O2 (1 mM)
as indicated. The cells were lyzed and JNK
activation determined by immunoblotting
with anti-phospho-JNK antibody.
(C) Diverse inhibitors of MKP activity en-
hance TNFα-induced PCD. wt or Jnk1−/− fi-
broblasts were incubated without or with
TNFα for 4 hr. DNCB (10 M), As3+ (100 M),
or H2O2 (1 mM) were added as indicated and
the cells were incubated for 4 more hr. Cell
viability was assessed by Trypan-blue exclu-
sion. Results are presented as averages ±
SD (n = 3).
(D) Catalytically inactive MKPs prolong JNK
activation. wt fibroblasts were transfected
with an HA-JNK1 plasmid (1 g) together
with expression vectors (4 g each) for wt or
catalytically inactive MKPs. After 24 hr, cells
were treated with 50 ng/ml of TNFα, and JNK
activity was determined by an immunecom-
plex kinase assay (KA) after immunoprecipi-
tation with anti-HA (αHA) antibodies.
(E) Catalytically inactive MKPs enable TNFα-
induced PCD of wt cells. Fibroblasts were
transfected with a GFP plasmid (1 g) to-
gether with expression vectors (4 g each)
for wt or catalytically inactive MKPs. After 24
hr, cells were treated with TNFα for 8 hr and
viability of GFP-positive cells was assessed
by PI dye exclusion and flow cytometry. Re-
sults are presented as averages ± SD (n = 3).of NF-κB (Karin and Lin, 2002; Varfolomeev and Ash- d
akenazi, 2004) or concomitant activation of TNFR2 (Wa-
jant et al., 2003), both of which potentiate JNK activa- a
rtion (Maeda et al., 2003). Whereas the IKK-NF-κB
pathway is an established negative regulator of the H
adeath response and its inhibition by cytokines, drugs
or toxins may cause various TNFα-mediated patholo- t
sgies, the role of the JNK cascade in determining the
biological response to TNFα has been more elusive. Ini- d
btial experiments using protein synthesis inhibitors either
found no role for JNK in modulation of TNF-induced cell J
death (Liu et al., 1996) or ascribed it with a protective
function (Natoli et al., 1997). However, more recent ex- a
cperiments carried out in cells in which NF-κB activation
was genetically inhibited demonstrated that JNK acti- u
wvation promotes TNF-induced cell death (De Smaele et
al., 2001; Deng et al., 2003; Tang et al., 2001; Varfolo- d
(meev and Ashkenazi, 2004). Nonetheless, JNK activity
per se is not a simple on-off switch and its level and puration determine its biological function, as transient
nd modest JNK activation is required for liver regener-
tion (Schwabe et al., 2003), whereas prolonged and
obust JNK activation promotes cell death (Lin, 2003).
ence, the mechanisms that control the level of JNK
ctivity serve as important contextual modulators of
he biological outcome of TNFR1 engagement. Our re-
ults show an important role for ROS, whose pro-
uction is induced by TNFα but is negatively regulated
y NF-κB, in enhancing the magnitude and duration of
NK activation through inhibition of JNK phosphatases.
Inhibition or downregulation of NF-κB prolongs JNK
ctivation not only in mammals but also in Drosophila
ells (Park et al., 2004). Nonetheless, the mechanism
nderlying this crosstalk had remained elusive. NF-κB
as suggested to attenuate JNK activation through in-
uction of GADD45b (De Smaele et al., 2001) or XIAP
Tang et al., 2001), but neither proposal received sup-
ort from studies conducted in Gadd45β- (Amanullah
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657Figure 7. Oxidative Stress Is iInvolved in ConA-Induced Liver Damage but Not in Liver regeneration
(A) wt and Ikkbhep mice were injected with the indicated doses of ConA (mg/kg). After 8 hr, mice were sacrificed and their livers removed to
determine GSH concentration. The average level of GSH in livers of untreated wt mice was given a value of 100%. Results are averages ± SD.
(B) ConA treatment downmodulates JNK phosphatase activity. Mice (wt) were injected with 25 mg/kg ConA in PBS and sacrificed 8 hr later.
Liver cell lysates were prepared and examined for JNK phosphatase activity as described in Figure 2B.
(C) Consumption of BHA-containing diet shortens the duration of JNK activation after ConA administration but not after partial hepatectomy.
JNK activity in liver was measured after ConA injection or partial hepatectomy in mice fed either a normal diet or a diet containing 7 g/kg BHA.
(D and E) Consumption of BHA-containing diet prevents ConA-induced liver damage. Mice (wt) were fed either a normal or a BHA-containing
diet for 2 days prior to ConA injection. (D) After 8 hr, circulating levels of ALT were analyzed. Results are averages ± SD (n = 3). (E) The extent
of liver apoptosis was evaluated by TUNEL staining. Typical fields of stained liver sections are shown.
(F and G) BHA does not interfere with liver regeneration. Mice fed either normal or BHA-containing diet were subjected to partial hepatectomy.
(F) To determine the rate of DNA synthesis, mice were injected with BrdU at 34 hr after liver resection and sacrificed 2 hr later. BrdU
incorporation into hepatocytes was examined by immunohistochemical analysis. (G) The extent of PCNA and cyclin E expression at 36 hr
after partial hepatectomy (each lane represents a different mouse) or in a sham-treated mouse was determined by immunoblotting.
(H) NF-κB modulates the TNFα-induced death response through control of ROS accumulation and MKP activity. TNFα induces NF-κB and
JNK activation, as well as ROS production. NF-κB prevents ROS accumulation in part through induction of MnSOD. This preserves MKP
activity, some of which is induced by NF-κB, and ensures transient JNK activation and cell survival. If NF-κB is inhibited, ROS accumulate
and MKPs are inhibited, leading to sustained JNK activation and cell death.
Cell
658et al., 2003) or Xiap- (Kucharczak et al., 2003) deficient i
cells. It was also not clear why GADD45β or XIAP z
should only affect JNK activation by TNFα and not by (
IL-1. The observation that TNFα but not IL-1 stimulates p
ROS production in NF-κB-deficient cells provided 1
strong insight to the NF-κB-JNK crosstalk (Sakon et al., h
2003), and a role for ROS in modulating TNFα-induced H
PCD was also demonstrated (Wong et al., 1989). Al- (
though ROS accumulation and prolonged JNK activa- h
tion were initially connected to TNFα-induced necrosis N
(Sakon et al., 2003), a more recent study demonstrated l
their involvement in TNFα-induced apoptosis (Pham et
al., 2004). Our results show that ROS production con- T
tributes to both forms of death in cultured fibroblasts W
and in mice. Regardless of the PCD phenotype, none r
of the previous studies had explained how ROS pro- a
duction prolongs JNK activation, and a defined molec- o
ular target whose activity is affected by ROS was not w
heretofore identified. Our current findings identify JNK (
phosphatases as critical molecular targets for ROS ac- f
tion in the context of TNFα-induced PCD. h
The magnitude and duration of JNK activity are de- i
termined by the balance between activating kinases c
and inhibitory phosphatases. The MAP3K ASK1 was c
suggested to mediate JNK activation in response to o
H2O2 (Takeda et al., 2003), but neither others (Sakon et a
al., 2003) nor we could find evidence for its involvement i
in sustained JNK activation in NF-κB-deficient cells. In- t
stead, we found that in such cells TNFα inhibits the e
activity of JNK phosphatases, which belong to the MKP 1
group of PTPs. At least four MKPs, MKP-1, -3, -5, and s
-7, are inhibited through oxidation of their catalytic cys- c
teine in TNFα-treated NF-κB-deficient cells or upon in- i
cubation with H2O2. It is well established that the cata- o
lytic cysteine of PTPs is much more sensitive to s
oxidation than other cysteines because of its unusually
h
low pKa (Salmeen et al., 2003; van Montfort et al., 2003), s
leading to the suggestion that cysteine oxidation is an
c
important mode of their regulation. While most studies
Odemonstrating oxidative PTP inhibition have relied on
ttreatment with exogenous H2O2 (Lee et al., 1998; Savit- tsky and Finkel, 2002), partial and transient PTP oxida-
ttion was seen after growth factor stimulation (Lee et al.,
p1998; Meng et al., 2002). Our results show extensive
and long-lasting MKP oxidation in TNFα-treated NF-
mκB-deficient cells. This activity involves conversion of
othe catalytic cysteine to sulfenic acid, which can be re-
Hversed by incubation with reducing agents or upon
dremoval of oxidant pressure through Trx-dependent re-
tductases.
TThe same chemical properties of the catalytic cys-
tteine needed for MKP enzymatic activity are also re-
2sponsible for its sensitivity to H2O2, thereby precluding
ugeneration of catalytically active and oxidation-resis-
ttant MKP mutants that could have been useful for
oblocking persistent JNK activation. Nonetheless, using
dcatalytically inactive MKP mutants, we show that re-
Jduced MKP activity allows TNFα to kill NF-κB-compe-
tent cells in a JNK-dependent manner. A similar effect
tis achieved by inhibition of TrxR, whose activity is re-
equired for reactivation of oxidized MKPs.
sInterestingly, NF-κB is an important positive regulator
hof MKP activity. At least one MKP, MKP-3, is encoded
by an NF-κB-dependent gene (Li et al., 2002). Another tmportant NF-κB target gene codes for MnSOD, the en-
yme responsible for conversion of superoxide radicals
O2−) to H2O2 and their eventual elimination through
eroxidases, which convert H2O2 to H2O (Wong et al.,
989). Another NF-κB target gene encoding ferritin
eavy chain (FHC) is also involved in conversion of
2O2 to H2O and is likely to act downstream of MnSOD
Pham et al., 2004). As O2− and H2O2 are important in-
ibitors of MKP activity, by inhibiting their accumulation
F-κB maintains MKP activity, thereby preventing pro-
onged JNK activation (Figure 7H).
he Role of ROS in Programmed Cell Death
hile the results discussed above strongly support a
ole for ROS in PCD, the relationships between the two
re complex. Some investigators find ROS to mediate
nly TNFα-induced necrosis (Sakon et al., 2003),
hereas others implicate it in TNFα-induced apoptosis
Pham et al., 2004). We find that TNFα can induce both
orms of PCD in cultured cells and in mice once Ikkb
as been inactivated, and that both programs are inhib-
ted by BHA. Timecourse analysis reveals that H2O2 ac-
umulation parallels cytochrome c release from mito-
hondria. Importantly, inhibition of ROS accumulation
r reduced JNK activity prevent cytochrome c release
nd caspase 3 cleavage. Although the origin of TNFα-
nduced ROS remains to be identified, they are likely
o originate in the mitochondrion, where inhibition of
lectron transfer results in O2− buildup (Cai and Jones,
998; Newmeyer and Ferguson-Miller, 2003). This as-
umption is supported by the ability of the mito-
hondrial-specific enzyme MnSOD to suppress TNFα-
nduced ROS accumulation. Although the initial leakage
f cytochrome c from the mitochondrion may not be
ufficient for disruption of electron transfer and en-
ancement of ROS production (Newmeyer and Fergu-
on-Miller, 2003), the latter may augment cytochrome
release through oxidation of cardiolipin (Iverson and
rrenius, 2004; Nomura et al., 2000). Cardiolipin oxida-
ion may enhance mitochondrial targeting of tBID (Lut-
er et al., 2000), a proapoptotic cleavage product of BID
hat is generated in response to TNFα-mediated cas-
ase 8 activation (Li et al., 1998; Luo et al., 1998).
While the exact mechanism through which ROS pro-
ote cytochrome c release remain to be elucidated,
ur results strongly suggest that critical targets for
2O2-induced oxidation in the TNFα-triggered cell
eath process are the MKPs. By controlling the dura-
ion of JNK activation, whose activity is required for
NFα-induced cytochrome c release and caspase 8 ac-
ivation, through either jBID formation (Deng et al.,
003) or a cFLIP-dependent mechanism (L.C. and M.K.,
npublished data), as well as TNFα-induced necrosis,
he MKPs act as a switch that determines the outcome
f TNFα signaling. High MKP activity prevents cell
eath, whereas low MKP activity promotes sustained
NK activation and enhances cell death (Figure 7H).
As discussed above, partial hepatectomy leads to
ransient JNK activation that is required for liver regen-
ration (Schwabe et al., 2003), a TNFα-dependent re-
ponse (Yamada et al., 1997). Feeding mice with BHA
as no effect on this response because it does not in-
erfere with transient JNK activation. However, BHA
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sponse that requires sustained JNK activation. Given
the potential complications and augmented necrotic re-
sponse associated with caspase inhibitors (Cauwels et
al., 2003) and the emerging role of caspase 8 in cell
survival (Perfettini and Kroemer, 2003), we propose that
mitochondrially targeted antioxidants may present a
preferred and viable strategy for therapeutic interven-
tion with fulminant liver failure and even chronic dis-
eases, such as viral hepatitis and alcoholic cirrhosis.
Experimental Procedures
Plasmids, Cells, and Transfection
MKP-1 and MKP-3 cDNAs were amplified by the polymerase chain
reaction (PCR) from a human cDNA library. MKP-5, MKP-5(C258S),
MKP-7C, and MKP-7C(C244S) expression vectors were pro-
vided by Dr. E. Nishida (Kyoto University, Japan). Different substitu-
tion mutations were introduced into the MKP-1 and MKP-3 cDNAs
by PCR. The MnSOD expression plasmid was provided by Dr. T.Y.
Aw (Louisiana State University). Fibroblasts derived from Ikkb−/−,
RelA−/−, or Jnk1−/− mouse embryos, Cos7, and HeLa cells were cul-
tured in DMEM plus 10% fetal calf serum (FCS). Plasmids were
transfected into cells using Lipofectamine and Lipofectamine Plus
(Invitrogen) following manufacturer’s instructions.
Immunoblot Analysis
Whole-cell lysates were prepared in a buffer containing 20 mM Tris-
HCl (pH 7.4), 10 mM EGTA, 10 mM MgCl2, 1 mM benzamidine, 60
mM β-glycerophosphate, 1 mM Na3VO4, 20 mM NaF, 1 M APMSF,
1 g/ml aprotinin, 10 g/ml pepstatin, 10 g/ml leupeptin, 1 mM
DTT, and 1% Triton X-100. After 20 min centrifugation at 16,000 ×
g at 4°C, the supernatants were gel separated. For cytosolic ex-
tracts, cells were suspended in 50 mM PIPES (pH 7.4), 50 mM KCl,
5 mM EGTA, 2 mM MgCl2, 10 M cytochalasin, and 1 mM DTT.
Following 20 min incubation on ice, 220 mM mannitol and 68 mM
glycerol were added, and cells were lysed in a Dounce homoge-
nizer. After 20 min centrifugation at 16,000 × g at 4°C the superna-
tants were gel separated, transferred to nylon membranes, and im-
munoblotted with antibodies against Flag, Myc, actin (Sigma),
phospho-JNK, phospho-p38 (Cell Signaling), JNK1, p38α (Santa
Cruz), cytochrome c (Pharmingen), MnSOD (UBI), and caspase 3
(BD Transduction Labs).
Measurement of ROS Production
Fibroblasts (2 × 105 cells) were plated on 35 mm dishes and loaded
with CM-H2DCFDA (Molecular Probes). After 30 min, cells were col-
lected and analyzed using a flow cytometer (FACS Caliber) and the
CellQuest computer program.
Kinase and Phosphatase Assays
JNK immunecomplex kinase assay was performed as described
(Maeda et al., 2003) using an anti-JNK1 antibody (Santa Cruz) and
GST-cJun(1–79) as a substrate. To measure MKP-3 activity, GST-
MKP-3 was incubated with 20 mM p-nitrophenyl phosphate (PNPP)
in a phosphatase buffer containing 20 mM Tris-HCl (pH 7.4), 1 mM
MnCl2, and 0.1 mM MgCl2 at 37°C, and A415 was monitored as a
measure of substrate hydrolysis. To measure total JNK phospha-
tase activity, cells or livers were homogenized in 50 mM Tris-HCl
(pH 7.4), 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 1% Triton X-100,
2 mM DTT, 1 mM APMSF, 1 g/ml aprotinin, 10 g/ml pepstatin,
and 10 g/ml leupeptin. After 20 min centrifugation at 16,000 × g
at 4°C, JNK1/2 were removed from the supernatants by immuno-
precipitation, and the immunodepleted lysates were mixed with
phosphorylated JNK1 isolated from HeLa cells and incubated at
37°C. The reactions were terminated by addition of 2% SDS and
separated by SDS-PAGE. Dephosphorylation of phospho-JNK1
was monitored by immunoblotting.
Mass Spectrometry
Purified MKP-3 was digested with lysil-endopeptidase (Roche). The
digests (500 fmol) were combined with a 10-fold excess of matrixsolution containing 10 mg/ml α-cyano-4-hydroxycinnamic acid,
50% acetonitrile, and 0.1% trifluoroacetic acid and analyzed by
matrix-assisted laser desorption ionization time-of-flight (MALDI-
TOF) MS using a Voyager DE-PRO mass spectrometer (Applied
Biosystems). Internal reference standards were used for cali-
bration.
Analysis of Protein Oxidation
MKP redox state was monitored by labeling with the thiol-modify-
ing reagent F5M (Molecular probes) or electrophoretic mobility shift
on SDS-PAGE under nonreducing conditions. For F5M labeling,
GST-MKP-3 was incubated with 0.3 mM F5M in 20 mM Tris-HCl
(pH 7.4), 1 mM MnCl2, and 0.1 mM MgCl2 for 5 min on ice. The
reaction was stopped with100 mM DTT. After digestion with throm-
bin for 1 hr at 20°C, the digests were separated by SDS-PAGE.
Fluorescence intensities of gel-separated peptides were measured
at 490 nm with fluorescence-image analyzer (FLA3000; Fuji Film).
For the mobility shift assay, cell lysates were prepared using a
buffer containing 20 mM Tris-HCl (pH 7.4), 1% Triton X-100, 10 mM
N-ethylmaleimide (NEM), 1 mM APMSF, 1 g/ml aprotinin, 10 g/
ml pepstatin, and 10 g/ml leupeptin. The lysates were separated
by SDS-PAGE in the presence or absence of βME or DTT and im-
munoblotted.
Analysis of Liver Injury and Oxidative Stress
Livers were fixed in 4% formaldehyde, dehydrated, embedded in
paraffin, and sectioned (5 mm). TUNEL staining was performed as
described (Maeda et al., 2003). The serum level of ALT was mea-
sured using an assay kit (Sigma). GSH content was measured by an
enzymatic assay using glutathione reductase and 5,5#-dithiobis(2-
nitrobenzoic acid) (Anderson, 1985).
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.cell.com/cgi/content/full/120/5/649/
DC1/.
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